Completed Infection & Immunity Genetics & Molecular Biology

Defining the biological basis of Staphylococcus aureus carriage

In plain English

AI plain-English summary

Around one in five people carry *Staphylococcus aureus* bacteria permanently in their noses, yet no one knows why some people are carriers and others are not. This matters because carriers face a higher risk of serious *S. aureus* infections—ranging from skin abscesses to life-threatening sepsis—and the bacterium is a leading cause of hospital-acquired infections worldwide. The biological reasons for persistent carriage remain a black box, partly because previous studies have been too small or too narrow to untangle the many possible influences: a person’s genetic makeup, their immune system, the other microbes living in their nose, and lifestyle factors such as smoking or diet. The team will screen 25,000 healthy volunteers from two existing UK cohorts, sequence their nasal bacteria, and combine this with already-collected genome and lifestyle data. By running genome-wide association studies and other analyses, they aim to pinpoint which genetic variants, microbial species, and environmental factors determine whether someone becomes a long-term carrier. If successful, this fundamental science could reveal new targets for decolonisation therapies—for example, a probiotic nasal spray or a drug that blocks a host receptor the bacterium uses to stick to nasal cells. Reducing carriage rates in the population could lower infection risk for vulnerable patients, particularly those undergoing surgery or chemotherapy.

View original technical description
Staphylococcus aureus is major cause of infection worldwide. This bacterium persistently colonises the nose (its natural niche) in around 20% of the population, which increases their risk of S. aureus infection. Why some people carry S. aureus while others never do is not understood, but is likely to reflect a complex trait influenced by multiple factors. This may include the human genome, host immunity, the nasal microbiota, bacterial-nasal epithelial cell interactions and lifestyle choices. We propose that key determinants for S. aureus carriage can be defined in a powered cohort study in which these parameters are established. Our study will capitalise on existing cohorts (INTERVAL & COMPARE) of healthy volunteers who have been extensively characterised through human genome sequencing and phenotypic profiling. We will screen 25,000 INTERVAL participants for S. aureus carriage, and using sequencing methods define their nasal microbiota composition. We will use existing as well as generate additional data on lifestyle. These datasets will be mined during a series of genome-wide and phenotypic association studies to identify factors that influence the nasal microbiota and S. aureus carrier status. Selected phenotypic and genetic variants of interest will then be tested in relevant experimental systems.

View the original record at the funder ↗

Researchers

Carl Anderson (EPMC Awardee)Joan Geoghegan (EPMC Awardee)John Danesh (EPMC Awardee)Julian Parkhill (EPMC Awardee)Sharon Peacock (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

CARRIAGE: Understanding the biological basis of persistent carriage of Staphylococcus aureus in humans
CARRIAGE: a trial to investigate why some people carry Staphylococcus aureus in their nose while others never do
Characterising microbiome-mediated environmental pressures on S. aureus within two host niches
Nasal carriage of virulent staphylococcus aureus: A possible co-morbidity of COVID-19
Investigating the natural variability in virulence of Staphylococcus aureus using whole genome sequencing

Original classification

Collaborative Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.